SYMBIOSE financials
A multi-period view of the public annual-account figures reported for SYMBIOSE, with comparable measures and links to available source documents.
Company overviewRegistry number
0751807705
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for SYMBIOSE
2025 versus 2024
- Operating line
- €103,896
- EBITDA
- €43,742
- Total assets
- €84,115
- Equity
- €5,000
-14.8%
-19.6%
-50.7%
-72.1%
EBITDA margin +42.1% · Equity ratio +5.9%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.